๐ŸŽ Black Friday: up to 50% off of annual plans
Acuvi AB (publ) (STO:ACUVI)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
5.48
-0.08 (-1.44%)
Nov 20, 2026, 5:25 PM CET

Acuvi AB Earnings Call Transcripts

Fiscal Year 2026

  • Q3 sales were SEK 47m and adjusted EBITDA was SEK 6.4m; 9M cash flow improved to SEK 10.2m. Growth spending is being considered cautiously, while management flags a $3m TPA headwind next year.

  • Q2 saw net sales rise to SEK 50 million, but operating profit turned negative and gross margin dropped to 51%. Growth in PiezoMotor and Asian markets is strong, but the loss of a major U.S. deal poses a revenue challenge. Cost control and positive cash flow remain top priorities.

  • Q1 sales remained stable at SEK 51.2 million, but EBITDA fell due to non-recurring cost increases and accelerated depreciation. High-margin PiezoMotor nearly doubled sales, and new U.S. defense orders offset a lost med tech deal. Cash flow and APAC growth are key focus areas.

Fiscal Year 2025

  • Net sales rose 25% in Q4 and 18% for the year, driven by deeper customer relationships and a shift to in-house sales. Adjusted EBITDA was positive, but non-recurring costs weighed on reported results. 2026 targets include 10% top-line growth and higher EBITDA, with focus on high-margin products and new markets.

  • Business Update

    A precision technology firm is shifting to direct sales in key markets to boost margins and customer engagement, while maintaining distributor partnerships in Asia. Financial targets remain unchanged, the company is now cash flow positive, and M&A is a strategic priority.

Fiscal Year 2023

Fiscal Year 2022